1. Home
  2. RNXT vs MOVE Comparison

RNXT vs MOVE Comparison

Compare RNXT & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$0.85

Market Cap

36.4M

Sector

Health Care

ML Signal

HOLD

Logo Movano Inc.

MOVE

Movano Inc.

HOLD

Current Price

$8.20

Market Cap

8.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNXT
MOVE
Founded
2012
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.4M
8.9M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
RNXT
MOVE
Price
$0.85
$8.20
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$7.75
N/A
AVG Volume (30 Days)
185.9K
147.0K
Earning Date
11-13-2025
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$928,000.00
$500,000.00
Revenue This Year
$2,795.35
$1,460.71
Revenue Next Year
$272.69
$96.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.70
$4.67
52 Week High
$1.69
$62.80

Technical Indicators

Market Signals
Indicator
RNXT
MOVE
Relative Strength Index (RSI) 42.02 46.93
Support Level $0.89 $7.60
Resistance Level $1.00 $12.08
Average True Range (ATR) 0.07 1.18
MACD -0.00 -0.15
Stochastic Oscillator 7.06 19.15

Price Performance

Historical Comparison
RNXT
MOVE

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About MOVE Movano Inc.

Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

Share on Social Networks: